The Hormonal Treatment of Endometriosis and Adenomyosis : A Comprehensive Review of the Role of Hormonal Treatments in the Management of Pain and Infertility in Patients with Endometriosis and Adenomyosis

個数:
  • 予約

The Hormonal Treatment of Endometriosis and Adenomyosis : A Comprehensive Review of the Role of Hormonal Treatments in the Management of Pain and Infertility in Patients with Endometriosis and Adenomyosis

  • 現在予約受付中です。出版後の入荷・発送となります。
    重要:表示されている発売日は予定となり、発売が延期、中止、生産限定品で商品確保ができないなどの理由により、ご注文をお取消しさせていただく場合がございます。予めご了承ください。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 340 p.
  • 言語 ENG
  • 商品コード 9780443277573

Full Description

The Hormonal Treatment of Endometriosis and Adenomyosis: A Comprehensive Review of the Role of Hormonal Treatments in the Management of Pain and Infertility in Patients with Endometriosis and Adenomyosis is a comprehensive and practical reference to provide a thorough understanding of the effects of various hormonal treatments on endometriosis and adenomyosis lesions. It summarizes the latest evidence regarding the safety and efficacy of these treatments in managing pain associated with these conditions. Additionally, the book explores the evidence-based benefits of hormonal therapies in improving fertility chances for patients, both through natural conception and assisted reproductive technologies. It helps readers grasp the generalizability of current research findings and identifies existing research gaps, shedding light on new perspectives for future investigation. Through this comprehensive approach, the book serves as an invaluable resource for healthcare professionals, researchers, and patients alike.

Contents

1. The hormonal regulation of endometriosis and adenomyosis
2. The in-vitro and in-vivo effects of the hormonal agents on the endometriotic and adenomyotic lesions
3. The intraoperative morphological changes of the endometriotic lesions following the prolonged administration of various hormonal suppressive therapies
4. The ultrasonographic changes of adenomyosis and endometriosis after the prolonged administration of different hormonal treatments
5. The effectiveness of oral contraceptives in improving the endometriosis-related pain and the patients' quality of life
6. The role of Dienogest and other progestogens in the management of endometriosis-related pain
7. What to expect from the levonorgestrel-releasing intrauterine device in symptomatic patients with endometriosis?
8. The usefulness of less common hormonal treatment modalities in improving the endometriosis-related pain symptoms
9. The effectiveness of the gonadotropin-releasing hormone analogues in the treatment of endometriosis-associated pain
10. The effectiveness of oral contraceptives in managing the symptoms of adenomyosis
11. The role of levonorgestrel-releasing intrauterine device in the management of adenomyosis-related symptoms
12. The effectiveness of the gonadotropin-releasing analogues in managing adenomyosis and its related symptoms
13. Can the hormonal suppressive therapy reduce the risk of the postoperative endometriosis recurrence and endometriosis-associated cancer?
14. The influence of different hormonal therapies on the chances of normal conception in subfertile patients with adenomyosis and endometriosis
15. The effect of the prolonged precycle administration of gonadotropin-releasing hormone agonists on the IVF-ET outcomes in patients with endometriosis
16. The effectiveness of the progestin-primed ovarian stimulation protocol on the IVF-ET outcomes of patients with endometriosis
17. The effectiveness of the prolonged administration of Dienogest before ovarian stimulation in improving the IVF-ET outcomes in patients with endometriosis
18. How could the prolonged precycle administration of aromatase inhibitors affect the IVF-ET outcomes of patients with endometriosis?
19. The role of the prolonged precycle hormonal suppression in patients with adenomyosis undergoing IVF-ET
20. The effect of different endometrial preparation protocols on the frozen-thawed embryo transfer cycle outcomes in patients with adenomyosis and endometriosis

最近チェックした商品